Skip to content

Kayla K Tillett

3 papers in the library · publishing 2026

Papers

Sort Most recent Most cited

Amanita Muscaria Mushrooms: An Online Retail Assessment of Branded Retailers, 2025

Figshare September 19, 2026 Cassidy R Loparco, Kayla K Tillett, Matthew E Rossheim et al. preprint

Amanita muscaria mushrooms, known for their hallucinogenic effects, have grown in popularity and availability. However, use can cause delirium, coma, and death. Moreover, the US Food and Drug Administration (FDA) has stated that Amanita muscaria, its extracts, and certain constituents (muscimol, ibotenic acid, and muscarine) are unapproved additives that do not meet the Generally Recognized as...

Amanita Muscaria Mushrooms: An Online Retail Assessment of Branded Retailers, 2025.

Substance Use & Misuse September 19, 2026 Cassidy R Loparco, Kayla K Tillett, Matthew E Rossheim et al.

Objective: Amanita muscaria mushrooms, known for their hallucinogenic effects, have grown in popularity and availability. However, use can cause delirium, coma, and death. Moreover, the US Food and Drug Administration (FDA) has stated that Amanita muscaria, its extracts, and certain constituents (muscimol, ibotenic acid, and muscarine) are unapproved additives that do not meet the Generally...

Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions.

Journal of Studies on Alcohol and Drugs May 28, 2026 Cassidy R Loparco, Matthew E Rossheim, Kayla K Tillett et al.

Retail sales of intoxicants, including derived intoxicating cannabis products (DICPs) such as delta-8 tetrahydrocannabinol (THC) and hallucinogenic mushrooms, have rapidly increased throughout the US, despite their sale being federally illegal. This study assessed DICP and hallucinogenic mushroom availability in US smoke shops with differing DICP and psilocybin laws. In May-October 2025, using...

DOI: 10.15288/jsad.26-00013 (opens in new tab) Full text (opens in new tab) Hemp-derived cannabinoids Marketing Public health policy